OIS@AAO

Saunders Speaks to Allergan’s Innovative Culture

By Tom Salemi | November 23, 2015

Prior to the announcement of the Pfizer-Allergan combination, Allergan CEO and President Brent Saunders spoke with OISTV about how the pharma industry finds and foster…

Read More

Brent Saunders, President & CEO of Allergan

By Tom Salemi | November 19, 2015

Brent Saunders delivers a data-packed presentation about the state of innovation in the life sciences industry and discusses where ophthalmology fits into Allergan’s future. Participant:…

Read More

Transcend Medical

By Tom Salemi | November 18, 2015

The year 2015 represented a milestone for Transcend Medical – it completed a milestone study and filed a Premarket Approval for a minimally invasive glaucoma…

Read More

Ocular Therapeutix

By Tom Salemi | November 17, 2015

The company is evaluating sustained-release injectable anti-VEGF drug depots along with use of its proprietary hydrogel platform technology for anterior segment disorders (specifically pain and…

Read More

Visual Disorders In Space And How Ophthalmology Can Help

By Tom Salemi | December 8, 2014

View PDF Presentation Presenter: Dorit B. Donoviel, PhD Dr. Donoviel oversees the diverse portfolio of science and technology research and development projects at NSBRI that…

Read More

WaveTec CEO Tom Frinzi Hints at Plans for Future

By Tom Salemi | December 5, 2014

WaveTec CEO Tom Frinzi spoke to the ease of the deal that paired his company with Alcon, hints at plans for the future and explains…

Read More

Laurent Attias Explains How Alcon Will Maximize the Ora System’s Potential

By Tom Salemi | December 5, 2014

Laurent Attias, head of Global Commercial Strategy of Alcon, explains why the WaveTec Vision integration has gone so well and how Alcon will maximize the…

Read More

Jeff George’s Vision for Innovation at Alcon

By Tom Salemi | December 5, 2014

Jeff George, Global Head of Alcon, took a few minutes between panels and meetings to share his vision for innovation at Alcon and how the…

Read More

Q&A with Richard Lindstrom

By Tom Salemi | December 3, 2014

First adopter Richard Lindstrom, MD, details the role new technology play in ophthalmology. Speaking With: Richard Lindstrom, MD Dr Richard L Lindstrom, Founder and attending…

Read More

Q&A with Michael Brownell

By Tom Salemi | December 3, 2014

Michael Brownell, CEO of Gobiquity, explains how his company is turning smartphones into a critical diagonstic tool to treat pediatric vision. Speaking With: Michael Brownell…

Read More

How to Do M&A Well

By Tom Salemi | December 3, 2014

Highlights of a discussion between the ophthalmology sector’s top execs about how to do M&A right. Moderator: Jim Mazzo Jim Mazzo is the Executive Chairman…

Read More

CEOs Share Lessons from IPOs

By Tom Salemi | December 3, 2014

A panel of ophthalmology executives at the Ophthalmology Innovation Summit discuss the perks and pitfalls of going public. Moderator: David Guyer, MD Under Dr. Guyer’s…

Read More

SUBSCRIBE TO OIS NEWS

Get Our Weekly Newsletter About The Latest In Ophthalmic Innovation.

We respect your privacy and promise to never send you spam.

Something went wrong. Please check your entries and try again.